Concepedia

Theresa I. Brondstetter

TI

6

Publications

329

Citations

6

H-Index

2004

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Stanford University

Theresa I. Brondstetter is an author at Johnson & Johnson (United States) specializing in medicine, lung transplantation, and molecular pharmacology.

Top concepts

Publications per year

2004–2022

6

Publications

6

IL-7 Gene Therapy in Aging Restores Early Thymopoiesis without Reversing Involution

Joy A. Phillips, Theresa I. Brondstetter, Chauca A. English et al. · The Journal of Immunology · 2004 · 103 citations · Full text

Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter et al. · Molecular Pharmacology · 2011 · 72 citations

Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues

Mark D. Rosen, Hariharan Venkatesan, Hillary M. Peltier et al. · ACS Medicinal Chemistry Letters · 2010 · 62 citations · Full text

, , +18

Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation‐induced anaemia in rats

Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter et al. · British Journal of Pharmacology · 2015 · 43 citations · Full text

Machine Learning Algorithms to Differentiate Among Pulmonary Complications After Hematopoietic Cell Transplant

Husham Sharifi, Yu Kuang Lai, Henry Guo et al. · CHEST Journal · 2020 · 25 citations · Full text

, , +10

Rows per page

1–5 of 6